☆ 4.2 Article

NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer

BMC Pharmacology & Toxicology (2012)

Get Full Text
Add to Collection

Journal

BMC Pharmacology & Toxicology
Volume 13, Issue Suppl 1, Pages A82

Publisher

Springer Nature
DOI: 10.1186/2050-6511-13-s1-a82

Keywords

-

Categories

Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.